BPC-157 vs GHK-Cu: A Research Comparison
BPC-157 and GHK-Cu are both studied in tissue-repair research but are different classes of molecule working through different pathways. BPC-157 is a synthetic pentadecapeptide studied for angiogenesis and cytoprotection, largely in preclinical models. GHK-Cu is a copper-binding tripeptide with a long history in skin and matrix-remodeling research and an established role as a cosmetic ingredient. The canonical difference is peptide class and mechanism. Both are supplied for research use only.
The core difference: peptide class and pathway
The two compounds sit in different structural and mechanistic categories within the shared tissue-repair area. BPC-157 is a 15-amino-acid peptide derived from a partial sequence of a gastric protein, studied in preclinical models for angiogenesis, cytoprotection, and effects on growth-factor and nitric-oxide pathways. GHK-Cu is a three-amino-acid peptide coordinated to a copper(II) ion, studied for extracellular-matrix remodeling, collagen and elastin synthesis, and copper delivery in skin and connective tissue. One is a repair-signaling peptide, the other a copper-carrying matrix-remodeling peptide.
Structure and molecular profile
BPC-157 (molecular weight near 1419.5 g/mol) is a synthetic pentadecapeptide with no metal component, dissolving to a clear solution. GHK-Cu (molecular weight near 403.9 g/mol) is glycyl-histidyl-lysine coordinated to copper(II), which gives its reconstituted solution a characteristic blue color. Reported copper-complex weights vary by protonation convention, so confirm the exact value against the Certificate of Analysis.
Clinical and regulatory context
The two differ markedly in research maturity. GHK-Cu (copper tripeptide-1) is a well-established cosmetic-ingredient peptide studied extensively in dermatology and wound-healing research over several decades. BPC-157 is studied predominantly in preclinical and animal models, with limited human data, and has not been approved for human use. Neither is offered here as a medicine or cosmetic; both are research-use-only materials.
How each is studied
Research with BPC-157 focuses on angiogenesis, cytoprotection, and tendon, ligament, and gastrointestinal repair models. Research with GHK-Cu focuses on matrix remodeling, collagen synthesis, the antioxidant behavior of the copper complex, and skin and connective-tissue models. Because they cover complementary repair pathways, the two are sometimes combined in tissue-repair research blends. A protocol chooses BPC-157 for repair-signaling questions and GHK-Cu where copper-dependent matrix chemistry is the variable.
All products are intended strictly for in-vitro laboratory research and development use only. Not for human or veterinary use, not a drug, food, or cosmetic, and not intended to diagnose, treat, cure, or prevent any disease.